SCHEMBL13901207

SCHEMBL13901207

Bc1cnc(Nc2cccc(NC(=O)OC(C)C)c2)nc1NCCc1c[nH]cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 1/20 0.41
▸ MARK3 P27448 1/20 0.41
▸ MARK4 Q96L34 1/20 0.41
▸ TBK1 Q9UHD2 1/20 0.41
▸ SYK P43405 2/20 0.39
▸ EGFR P00533 8/20 0.39
▸ JAK3 P52333 2/20 0.39
▸ ITK Q08881 5/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ CCNT1 O60563 1/20 0.38
▸ CCNE1 P24864 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ BTK Q06187 3/20 0.37
▸ KIT P10721 1/20 0.37
▸ ULK1 O75385 1/20 0.37
▸ PDK1 Q15118 1/20 0.37
▸ ULK2 Q8IYT8 1/20 0.37
▸ BRD4 O60885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13901398 0.91 TBK1 (0.43) AURKAMARK3MARK4TBK1SYK
SCHEMBL3863970 0.90 TBK1 (0.51) AURKAMARK3MARK4TBK1SYK
SCHEMBL13901416 0.87 EGFR (0.53) AURKAMARK3MARK4TBK1SYK
SCHEMBL13901339 0.87 AURKA (0.42) AURKAMARK3MARK4TBK1SYK
SCHEMBL13901446 0.86 EGFR (0.45) AURKAMARK3MARK4TBK1SYK
SCHEMBL13901400 0.86 EGFR (0.43) AURKAMARK3MARK4TBK1SYK
SCHEMBL13901438 0.84 PTK2 (0.45) AURKAMARK3MARK4TBK1SYK
SCHEMBL13901411 0.82 SYK (0.37) AURKASYKEGFRJAK3ITK
SCHEMBL13901212 0.82 TBK1 (0.60) AURKAMARK3MARK4TBK1EGFR
SCHEMBL13901504 0.82 BRD4 (0.44) AURKAMARK3MARK4TBK1JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 — — US disclosed
Send feedback